Studies Open to Recruitment
Qualitative exploration of PARP-i long term users in advanced ovarian cancer
This research project is about the experiences of people with recurrent ovarian cancer who have responded to PARP-inhibitor therapy for an extended period of time. For this cohort of people, it is unclear how long therapy should be continued, particularly due to some concerns about long term side effects.
